Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types
- 20 April 2023
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 16 (4) , e250972
Abstract
Amyloid transthyretin amyloidosis usually presents with cardiac amyloidosis manifestations, most commonly with a heart failure syndrome. The history and physical examination offer clues of other cardiac and extracardiac manifestations. Taking a detailed history is essential in elucidating pertinent family and medical history that may increase suspicion for amyloidosis. Further, certain findings on electrocardiogram and imaging should raise suspicion and trigger further workup that can confirm the diagnosis, since treatment is evolving.Keywords
This publication has 22 references indexed in Scilit:
- PACEMAKER IMPLANTATION IN PATIENT WITH PERSISTENT LEFT SUPERIOR VENA CAVA (SVC) WITH ABSENT RIGHT SVCJACC, 2019
- Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain ImagingCurrent Cardiology Reports, 2019
- Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkersBMC Cardiovascular Disorders, 2018
- A new staging system for cardiac transthyretin amyloidosisEuropean Heart Journal, 2017
- Cardiac Amyloidosis: Diagnosis and Treatment StrategiesCurrent Oncology Reports, 2017
- The Relation of Ejection Fraction and Global Longitudinal Strain in Amyloidosis: Implications for Differential DiagnosisJACC: Cardiovascular Imaging, 2016
- Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imagingJournal of Internal Medicine, 2014
- The Systemic AmyloidosesNew England Journal of Medicine, 1997
- Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agentsThe American Journal of Cardiology, 1985